How to Accelerate Early Stage of Malaria Vaccine Development by Optimizing Functional Assays
While two <i>Plasmodium falciparum</i> circumsporozoite protein-based pre-erythrocytic vaccines (PEV), RTS,S and R21, have been approved by the WHO, no blood-stage vaccine (BSV) or transmission-blocking vaccine (TBV) has reached a phase 3 trial. One of the major obstacles that slows down malaria vac...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2024-05-01
|
| Serie: | Vaccines |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2076-393X/12/6/586 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|